I think we looking good here and $FUTL :)

not good but GREAT call by you

$FUTL Volume is Expanding for a #BullRun

$FUTL Volume is Expanding for a #BullRun

$FUTL Volume is Expanding for a #BullRun

$BCCI yes, swing fro 200 day
I bought .018

$GTXI ready for 1 line push

$NETE hmmm may be ready here

$BXE may be ready here

I should of bought GV forgot

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=124927048&txt2find=gv

just $PME I sold $ALN for loss and flat $KBSF

$DEWM we started today

$PME $ALN I love these 2---and Orions!

$ALN next China here Deutsche Investitions reports 28.2 pct stake in American Lorain http://reut.rs/2cKAwVZ via @Reuters

$ALN Deutsche Investitions reports 28.2 pct stake in American Lorain http://reut.rs/2cKAwVZ via @Reuters has me bullish

$ALN Deutsche Investitions reports 28.2 pct stake in American Lorain http://reut.rs/2cKAwVZ via @Reuters has me bullish

nice looking chart

$EDXC think we can see 100% here to start on swing on reversal

$GTXI has real nice Q4 catalyst coming

Enobosarm, a selective androgen receptor modulator (SARM), is the Company’s lead product candidate and is being developed as a targeted treatment for two advanced breast cancer indications: estrogen receptor positive (ER+) and androgen receptor positive (AR+) breast cancer, and AR+ triple negative breast cancer (TNBC). Preliminary data from the first stage of both Phase 2 clinical trials are expected by the end of 2016, which will allow us to determine whether we will enroll additional patients in the second stage of each clinical trial.

$ALN .63 look at volume increasing of late

$GTXI another swinging for 1 line first

$CBIO presents tomorrow, looking for another $INFI into presentation which is 1.80 Ah's

$INFI 1.47 presenst tonight 6pm at CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference 2.40 in Cash pic.twitter.com/Ga1eK9y7oy

— Beach Trades (@beach_trades) September 26, 2016

$CBIO 1.25 took some as presents tomorrow at the Ladenburg Thalmann 2016 Healthcare Conference https://t.co/DZSRzdzNV3 pic.twitter.com/XJy1kNHwmB

— Beach Trades (@beach_trades) September 26, 2016

$GTXI swinging about .76 avg in Q4 catalyst

Enobosarm, a selective androgen receptor modulator (SARM), is the Company’s lead product candidate and is being developed as a targeted treatment for two advanced breast cancer indications: estrogen receptor positive (ER+) and androgen receptor positive (AR+) breast cancer, and AR+ triple negative breast cancer (TNBC). Preliminary data from the first stage of both Phase 2 clinical trials are expected by the end of 2016

$GTXI believe can be nice swing into Q4 catalyst pic.twitter.com/JDBvAOZJid

— Beach Trades (@beach_trades) September 26, 2016

what charts say for $TGD $BAA $GSS $PZG as well

$ALN--was it you or Kajulie back in day say something about u can't hold beachball under water for long, eventually it pops

looks good AF! $TGD $BAA $PZG $GSS my basket now will add $VGZ

$EDXC POT

$ALN

$ALN we got 28% stake reported last week, I think big run coming http://ih.advfn.com/p.php?pid=nmona&article=72450638

$ALN expecting large move here move coming in china here

$XNY nice lil pop today

any link to M&A?

$XNY do you have link for that

TIA

$XNY China Retail Numbers up http://www.ft.com/fastft/2016/09/13/china-retail-industrial-production-beat-expectations-in-august/

$XNY China Retail Numbers up http://www.ft.com/fastft/2016/09/13/china-retail-industrial-production-beat-expectations-in-august/

$CCCL ready as China's economy shows signs of strengthening after better-than-expected economic from data http://bloom.bg/2c6RwWG

$ZX going to follow $SORL

$ZX at 1:15 has over three dollars in cash

Mr. Billington has previously entered into a 10b-5 plan to sell up to 1,000,000 shares of which 815,195 remain

almost done then will fly for november

$PME this is your next #BEAST!

$RCON #lowfloat #china and #oil

$SSN #smallcap #oil my next $TAT ready for 1 line move